Marijuana Use Before Sex Leads to More Satisfying Orgasms, Study Finds

Kimberly Lawson, writing for Marijuana Moment:

Want a more satisfying time in the bedroom? A quick toke or two may do the trick, according to a new study in the journal Sexual Medicine.

While scientific evidence about the effects of marijuana use on sexual functioning is limited, there’s plenty of anecdotal claims online about cannabis improving libido, arousal and orgasm. So researchers decided to investigate, publishing one of the largest studies on the issue to date.

After reading the title of this post, you’re probably thinking to yourself, “…no duh.” Well, the results may not be all that surprising, but this is really intriguing research. There’s still plenty more to learn about how cannabis affects sex, but preliminary studies like this one are laying the foundation that is needed to even get around to performing more rigorous research.

FDA Flooded With Comments Urging That Marijuana Be Reclassified

Kyle Jaeger, writing for Marijuana Moment:

In the last few days, nearly 700 people have submitted comments to the Food and Drug Administration (FDA) supporting the rescheduling of marijuana.

The FDA opened the public comment period on Friday to gather input ahead of a United Nations meeting on global drug policy, where the U.S. representative will have the opportunity to cast a vote on World Health Organization (WHO) recommendations to reschedule cannabis, THC and CBD under international drug treaties.

So far, the federal agency has been flooded with comments that overwhelmingly endorse a cannabis reclassification. Support for the policy change has been nearly unanimous, but the reasoning behind those sentiments varied.

The deadline for this round of comments is March 14th, so make sure you submit yours before it’s too late. Last time the FDA asked for input on this issue, more than 20,000 people submitted their feedback. As a community, we should shoot for even more this time around. Tell the FDA what you think about rescheduling cannabis today.

Legal Cannabis Has Created 211,000 Full-Time Jobs in America

Bruce Barcott, writing for Leafly:

Over the past three months Leafly’s data team, working in partnership with Whitney Economics, has gone state-by-state to tally the total number of direct, full-time jobs in the state-legal cannabis industry.

There are now more than 211,000 cannabis jobs across the United States. More than 64,000 of those jobs were added in 2018. That’s enough people to fill Chicago’s Soldier Field, with 3,000 more tailgating outside.

Legal cannabis is currently the greatest job-creation machine in America. The cannabis workforce increased 21% in 2017. It gained another 44% in 2018. We expect at least another 20% growth in jobs in 2019. That would represent a 110% growth in cannabis jobs in just three years.

When the country chooses to finally legalize cannabis at the federal level, we will definitely have plenty of opportunities for people to find meaningful work.

A New Chapter in the Science of Psychedelic Microdosing

Haley Weiss, writing for The Atlantic:

The purported benefits of microdosing psychedelics are as numerous as the research is sparse. The technique, which involves ingesting small amounts of LSD, mushrooms, or other hallucinogenic drugs every three or four days, has made headlines for its popularity as a “productivity hack” among the Silicon Valley elite. But anecdotal endorsements of microdosing claim that the routine can lead to a whole variety of benefits, including heightened emotional sensitivity, athletic performance, and creativity; and relief from symptoms of anxiety, depression, OCD, PTSD, and chronic pain—all without resulting in any sort of trip.

In a lab setting, meanwhile, these effects have hardly been studied. Microdosing straddles a line between homeopathic remedy and experimental biohacking as a promising tool that hasn’t yet made its way through the clinical system’s rigorous checks and balances. Now a new study published Monday in the journal ACS Chemical Neuroscience provides the first biological evidence that psychedelic microdosing could have unique therapeutic effects that differ from the effects of a full dose.

New research found that microdosing DMT produced positive effects on mood and anxiety in rats without impacting working memory or social interaction. This is exciting news.

However, the study also found that the female rats experienced a decrease in dendritic-spine density, while the male rats were unaffected. This is concerning because it could indicate that these minuscule doses of the drug may have caused certain damage to this particular area of the brain. What’s odd is that bigger doses of DMT haven’t produced this cytotoxic effect.

So while microdosing may be able to assist with mental health issues, more research will need to be conducted to determine exactly what is going on with the female rats.

What It’s Like to Smoke Salvia for Science

Daniel Oberhaus, writing for Motherboard:

In 2008, a report by the New York Times pointed to an abundance of online videos of people experimenting with salvia as “exhibit A” in the push to make the substance illegal throughout the United States. But it wasn't just the videos. The stigma around salvia is also due to the nature of the trip itself, which is characterized by its vivid hallucinations and intense dissociative effects. Almost everyone I know has either tried salvia or knows someone who has, but I’ve yet to meet anyone who enjoyed the experience.

Although I’ve had several unpleasant salvia experiences myself, I recently volunteered to be a participant in the first-ever brain imaging study on salvinorin A, the main psychoactive compound in the salvia plant. Only a handful of salvia studies have ever been conducted on human subjects and this study was the first time that researchers were able to watch the brain as it was tripping on salvinorin.

Tripping in an MRI machine is intimidating enough as it is, but tripping on the hardcore psychedelic dissociative salvia divinorum in an MRI machine really takes the cake. Kudos to Daniel and all the other brave participants in this study. His account is well-worth reading and the experiment went better than you might think.